Find trials
Search tips

A Study of the Safety and Effectiveness of Home Monitoring of Blood Clotting Factors in Adults with Congenital Heart Disease

Overview

About this study

The purpose of this study is to compare the safety and effectiveness of home monitoring of INR (blood clotting factors) to standard of care clinic monitoring for adults with congenital heart disease.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

  • Age >18 years 
  • Existing diagnosis of Congenital Heart Disease
  • On warfarin therapy 
  • Have been using home INR monitoring devices for a period of at least one year

 

Exclusion Criteria

  • Use of INR home monitoring device for less than one year

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Heidi Connolly, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

More about research at Mayo Clinic

.
CLS-20304381

Mayo Clinic Footer